1 To whom correspondence should be addressed metriosis-associated infertility remain to be completely The present study is the first prospective randomized clarified (Hill, 1992) . Recently, however, different studies have controlled trial of the effect of pentoxifylline on future suggested that immunological mechanisms are involved in fertility in infertile women with asymptomatic minimal or the pathophysiology of endometriosis-associated reproductive mild endometriosis. After completion of a basic infertility failure (Mahmood and Templeton, 1990; Hill, 1992 ; Ramey workup and laparoscopy, patients were entered into the and Archer, 1993; D'Hooghe and Hill, 1996; Oral et al., 1996 ; study and randomly allocated to receive either a 12 month Prentice and Ingamells, 1996; Vinatier et al., 1996 ; Martinezcourse of oral pentoxifylline (800 mg/day) (n ⍧ 30) or an Román et al., 1997) . On the other hand, considerable evidence oral placebo (n ⍧ 30). Those patients with other infertility already exists in animal models to suggest that immunofactors were included in the study only if the factors modulation, through a variety of non-specific immunomodulawere correctable and ultimately determined to be nontors such as pentoxifylline, affects both endometriotic implant contributory. Life-table analysis was used to compare growth and endometriosis-associated infertility (Steinleitner pregnancy rates between the two groups over a 12 month et al., 1991a, b, c; Nothnick et al., 1994) . On this clinical and period that started immediately after laparoscopy. The 12 experimental evidence, and since all other treatment concepts month actuarial overall pregnancy rates were 31 and have failed, it has been stressed that prospective trials of 18.5% in the pentoxifylline and placebo groups respectively.
immunological treatments are urgently needed (Evers, 1993; However, this difference was not statistically significant by Nothnick et al., 1994; Gleicher, 1992 Gleicher, , 1995 . the χ 2 -test. Similarly, the Cox regression method showed
The present report is the first prospective, randomized no differences between the hazard of pregnancy in the two clinical study comparing immunomodulation and placebo for groups studied (odds ratio, 0.56; 95% confidence interval, treatment of endometriosis-associated subfertility. 0.18-1.67). Therefore, there is no evidence from this study that immunomodulation with pentoxifylline aids fertility Materials and methods in those women with minimal or mild endometriosis.
The study was a prospective randomized controlled blind trial, of the Further studies including more infertile patients with endoeffect of pentoxifylline on future fertility in infertile women with metriosis are desirable in order to confirm our results. therapy is an ineffective treatment for this condition (Evers, Diagnosis of endometriosis was made in all cases by laparoscopy as previously reported (Balasch et al., 1996b; Martínez-Román et al., 1989 , 1993 Hughes et al., 1993; Adamson and Pasta, 1994). 1997) . A systematic laparoscopic evaluation of all pelvic peritoneal correctable infertility factors and additional infertility treatsurfaces was carried out in all patients. Endometriosis was staged ments were also similar for both study groups.
according to the revised American Fertility Society (AFS, 1985) The 12 month actuarial overall pregnancy rates were 31% scoring. Superficial ovarian and peritoneal endometriosis was classiand 18.5% in the pentoxifylline and placebo groups, respectfied as recently suggested by Brosens et al. (1993) as follows: red ively. However, this difference was not statistically significant lesion (flame-like lesion, or a haemorrhagic vesicle or a vascularized by the χ 2 -test. Similarly, the Cox regression method showed polypoidal or papular lesion); black lesion (a puckered, black lesion); no differences between the hazard of pregnancy in the two white lesion (scarred tissue with or without some pigmentation).
groups studied (odds ratio, 0.56; 95% confidence interval, Biopsies of suspicious lesions were taken when the visual diagnosis of 0.18-1.67) (Figure 1 ). One patient in each study group became endometriosis was in doubt (four cases). Biopsy of the endoscopically pregnant but miscarried at 7 and 8 weeks gestation, respectively. suspected endometriosis revealed the presence of endometrial glands and stroma in three cases, while the remaining biopsy showed Both women conceived again under the same treatment and endometrium-like stroma alone. The latter case was considered as carried to term. These two pregnancies were not included for negative for endometriosis. All laparoscopies included tubal dye statistical analysis of results. When patients were categorized perfusion.
as pregnant or non-pregnant, according to treatment regimen, Patients were entered immediately after laparoscopy and all of again the presence of corrected additional infertility factors them gave written informed consent. They were assigned according did not appear to influence the rate of pregnancy by Fisher's to a computer-generated randomization list to one of the following exact test (Table II) .
treatments: oral pentoxifylline (Elorgán, Grupo Roche SA, Barcelona, Spain) 400 mg twice daily (n ϭ 30) or an oral placebo (n ϭ 30) to be taken twice daily. Patients were then observed for pregnancy for Discussion 12 months. During this period, other infertility factors such as male It has been estimated that 25-50% of infertile women have problems, ovulatory defects, and cervical mucus abnormalities, were treated with appropriate therapeutic modalities including intrauterine evidence of endometriosis, and 30-50% of women with insemination with husband or donor semen and/or ovulation induction. endometriosis are infertile (Mahmood and Templeton, 1990;  It is important to note that patients who had been treated for additional Christman and Halme, 1992) . Therefore, endometriosis is one correctable infertility factors before laparoscopy, received the same of the most important gynaecological diseases affecting the additional infertility treatments during the same number of cycles fertility potential of women. Most infertile women having after endometriosis was diagnosed. This was also true for those patients endometriosis present with minimal to mild forms of the empirically treated with intrauterine insemination plus ovulation disease for which no definite therapeutical approach exists. In induction before laparoscopy (two women in the pentoxifylline group fact, it has been recently stressed that, in endometriosisand one case among patients receiving placebo). Thus, patients were associated subfertility, it has never been proven satisfactorily their own control for additional infertility factors which adds to the that medical treatment works, and the same holds for surgery homogeneity of the study groups. Pregnancy was confirmed by and laser laparoscopy (Evers, 1989 (Evers, , 1993 Hughes et al., 1993;  ultrasonography.
Groups were compared by χ 2 analysis and the Mann-Whitney Adamson and Pasta, 1994; Gleicher, 1992 Gleicher, , 1995 metriosis are urgently needed (Evers, 1993; Gleicher, 1992 Gleicher, , 1995 . Endometriosis has, in recent years, been characterized by a Results large number of immunological abnormalities in the host and there is substantial evidence that immunologic factors A total of 60 eligible consecutive patients were entered into the study between November 1993 and December 1995. Thirty play a role both in the pathogenesis of endometriosis and endometriosis-associated reproductive failure (Mahmood and of these patients were designated as 'pentoxifylline patients' and 30 as 'placebo patients'. One woman in the pentoxifylline Templeton, 1990; Hill, 1992; Ramey and Archer, 1993; D'Hooghe and Hill, 1996; Oral et al., 1996 ; Prentice and group and three of the placebo patients were discarded because they refused to start treatment after being randomized (one Ingamells, 1996; Vinatier et al., 1996) . Thus, in a recent study (Martínez-Román et al., 1997) investigating immunologic case) or because of the patient's failure to continue taking the medication (three cases). Thus, in total, the responses of 56 factors in fertile and infertile women with and without endometriosis, we concluded that immunologic mechanisms patients to pentoxifylline (n ϭ 29) or placebo (n ϭ 27) were evaluated. All these 56 patients took the drug or placebo of endometriosis-associated infertility exist but these peritoneal immunological factors in infertile women with endometriosis regularly and actively tried to become pregnant during the study period.
are a function more of their subfertility than of their ectopic endometrial implants. This is supported by the lack of immunolBaseline characteristics of the patients and the distribution of other infertility factors in each study group are shown in ogic abnormalities observed among fertile women with endometriosis. These immunological abnormalities are lacking in Table I . There were no significant differences between groups regarding age, duration of infertility, prevalence of endopatients with unexplained infertility. If peritoneal macrophages are involved in the pathogenesis metriosis by revised AFS (1985) classification, and diagnosis of appearances of the condition. The frequency of additional of endometriosis and endometriosis-associated subfertility, Figure 1 . Overall 12 month probability of becoming pregnant in 56 subjects with minimal or mild endometriosis according to treatment allocation. AFS ϭ American Fertility Society. IUI ϭ intrauterine insemination. There were no significant differences between the groups. either the disruption of macrophage function or interference phages, into syngeneic mice significantly inhibited fertilization. This fertility-lowering effect of activated macrophages was in the release of secretory products should result in regression or suppression of endometriosis and/or its associated reversed by periovulatory administration of pentoxifylline, a methylxantine derivative. Similarly, they found that perisymptoms (Ramey and Archer, 1993) . Experimental studies by Steinleitner et al. (1991a, b, c) support this contention.
ovulatory treatment with pentoxifylline abrogated the adverse influence of endometrial explants on fertilization in the rodent These authors showed that the intraperitoneal transfer of hyperactivated macrophages, but not of basal state macromodel. A variety of mechanisms has been proposed to account for these observations (Steinleitner et al., 1991a, b) . Pentoxifylarm of the study and pregnancy rates as one of their endpoints (Seibel et al., 1982; Thomas and Cooke, 1987; Bayer et al. , line inhibits phagocytosis and generation of toxic oxygen species and proteolytic enzymes by macrophages and granulo-1988; Telimaa, 1988; Fedele et al., 1992) . A second limitation of our study, which is also shared with those previous studies cytes in vitro and in vivo; it inhibits tumour necrosis factor production in vitro; and it reduces the inflammatory action of on hormonal therapy, is that 40-45% of patients had additional infertility factors. However, a thorough infertility evaluation tumour necrosis factor and interleukin 1 on granulocytes in vitro. Thus, pentoxifylline influences both the production was carried out in all patients, those cases with untreatable confounding factors were excluded, and all defects thought to of inflammatory mediators and the responsiveness of immunocompetent cells to inflammatory stimuli. Pentoxifylline has be contributing to subfertility were corrected. In addition, χ 2 analysis showed that these confounding factors had no signialso been used to enhance sperm motility and the outcome of in-vitro fertilization in couples suffering from male infertility ficant effect on pregnancy rates among the two study groups. Finally, pentoxifylline dosage (800 mg/day) used in our study (Tournaye et al., 1994; Matson et al., 1995) . Therefore, a direct effect on sperm motility has also been advocated by was selected arbitrarily on the basis of the manufacturer's recommendations while a dosage of 400-1200 mg/day was Steinleitner et al. (1991a, b) to explain their results. Finally, it should be noted that a recent experimental study showed used for the treatment of idiopathic male factor infertility (Tournaye et al., 1994) . This dose, however, is twice as that pentoxifylline can modulate rat endometriotic implant growth and production of implant-specific proteins (Nothnick high as the dose of pentoxifylline (5 mg/kg body weight) successfully used to modulate endometriotic implant growth et al., 1994) .
From their studies, Steinleitner et al. (1991a, b) and Nothnick and production of implant-specific proteins in the rat model (Nothnick et al., 1994 (Nothnick et al., ). et al. (1994 concluded that immunomodulation of peritoneal inflammatory cell hyperactivation with pentoxifylline may In summary, the present pilot study failed to show any impact of treatment of asymptomatic endometriosis with penrepresent a new modality specifically to treat the essential pathophysiology of endometriosis-associated subfertility. Evers toxifylline on future fertility. Further studies including more patients ideally having endometriosis but not additional infertil-(1993) and Gleicher (1995) stressed that since all other treatment concepts have failed, there is nothing to lose by ity factors are desirable in order to confirm our results. designing new experimental treatment approaches towards endometriosis that are based on immunomodulation. However, so far, such studies in the human have not been reported. References The present study represents the first report investigating
